Literature DB >> 25457993

[Preventing chronic kidney disease in France: advantages, feasibility and concerns].

Flore Duranton1, Philippe Brunet2, Maurice Laville3, Paul Landais4, Jean-Pierre Daurès4, Georges Mourad5, Montserrat Bustins6, Angel Argilés7.   

Abstract

Chronic kidney disease concerns 10 to 14 % of Western populations, and these people are at increased risk of mortality. Treating those patients who reach end-stage renal disease is socially and financially costly and requires considerable medical efforts. While the number of nephrologists per inhabitant in France seems to be preserved over time, the increasing prevalence of end-stage renal disease and improvement in early referral of chronic kidney disease patients results in increased workload for renal physicians. In order to reduce the consequences of chronic kidney disease at both, individual and societal levels, promoting primary prevention (elimination of risk factors), secondary prevention (early management of patients) or tertiary prevention (optimal treatment of functional disabilities related to chronic kidney disease) seems relevant. Some of these actions could narrow the gap between current medical practices and recommendations or prevent new end-stage renal disease cases with an acceptable cost-effectiveness ratio. New approaches might be necessary to better control the disease and overcome current limitations such as resistance to treatments.
Copyright © 2014 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Insuffisance rénale; Maladie rénale; Prevention; Prévention; Public health; Renal insufficiency; Santé publique

Mesh:

Year:  2014        PMID: 25457993     DOI: 10.1016/j.nephro.2014.06.007

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  1 in total

1.  [A retrospective study on the incidence of chronic renal failure in the Department of Internal Medicine and Nephrology at University Hospital of Antananarivo (the capital city of Madagascar)].

Authors:  Benja Ramilitiana; Eliane Mikkelsen Ranivoharisoa; Mihary Dodo; Evanirina Razafimandimby; Willy Franck Randriamarotia
Journal:  Pan Afr Med J       Date:  2016-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.